Related topics: red blood cells

What's holding up CRISPR-based cures

The gene-editing tool called CRISPR that can quickly and cleanly remove specific pieces of DNA has revolutionized biotechnology. Many researchers believe the technique could end thousands of ailments. So what's needed to ...

Scientists use light to uncover the cause of sickle cell disease

In sickle cell disease, hemoglobin—the oxygen-carrying component of blood—forms fibers that stiffen red blood cells and cause life-threatening symptoms. Using light-scattering techniques to study the detailed thermodynamics ...

The good side of carbon monoxide

Most people think of carbon monoxide as harmful, and with good reason—the colorless, odorless gas sends 50,000 people in the U.S. to hospitals each year when their furnaces malfunction or car engines run in poorly ventilated ...

A banner year for pharma

As 2018 draws to a close, the pharmaceutical industry is celebrating a prosperous year of new investments and therapeutic breakthroughs. These successes were driven by cutting-edge science and progress in finally translating ...

The state of CRISPR research

CRISPR has been hailed as one of the most promising gene editing technologies and promises to revolutionize precision medicine and eradicate genetic diseases. However, the technique is not perfect and needs improvements. ...

Global Blood Therapeutics latest biotech to double in debut

Blood disorder drug developer Global Blood Therapeutics shares more than doubled Wednesday as the company became the latest biotechnology company to get a powerful response from investors in its stock market debut.

page 6 from 6